NCT00004751

Brief Summary

OBJECTIVES: I. Assess the efficacy and safety of selective dorsal rhizotomy and physiotherapy compared with physiotherapy alone in improving gross motor function and reducing spasticity in children with spastic diplegia.

Trial Health

50
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 1991

Completed
8.4 years until next milestone

First Submitted

Initial submission to the registry

February 24, 2000

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 25, 2000

Completed
Last Updated

June 24, 2005

Status Verified

February 1, 1997

First QC Date

February 24, 2000

Last Update Submit

June 23, 2005

Conditions

Keywords

cerebral palsyneurologic and psychiatric disordersrare diseasespastic diplegia

Interventions

SurgeryPROCEDURE

Eligibility Criteria

Age3 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
PROTOCOL ENTRY CRITERIA: --Disease Characteristics-- * Spastic diplegia, i.e.: Measurable spasticity with more lower than upper limb involvement * Fair to good trunk and head control * Little or no bulbar involvement * Able to walk or has potential to walk indoors with assistive devices * No fixed musculoskeletal deformity greater than 15 degrees * Prior orthopedic surgery acceptable if spastic muscle group is in physiologic biomechanical position and retains voluntary power * No detectable athetosis, rigidity, ataxia, or other movement disorder * No disease-related, treatable condition that may become urgent during study, e.g., hip subluxation requiring adductor release --Patient Characteristics-- * Age: 3 to 18 * Other: Intelligence Quotient greater than 50 Developmental age 3 years or higher * Able to follow multi-step commands * Expressive communication skills at 3-year level or higher * Mild dysarthria or drooling does not exclude * Stable social environment * Regular school and physical therapy attendance * Normal psychiatric status * Guardian able to give support and follow-up care * No medical contraindication to anesthesia or surgery, e.g.: Previous anesthesia reaction * Chronic lung disease * Uncontrollable seizures * Scoliosis Vertebral anomaly * Neural tube defect * No visual impairment sufficient to hinder mobility * Able to come to Children's Hospital and Medical Center for follow-up Insurance coverage adequate for surgery and postoperative physiotherapy

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

MeSH Terms

Conditions

Cerebral PalsyNeurologic ManifestationsMental DisordersRare Diseases

Interventions

Surgical Procedures, OperativePhysical Therapy Modalities

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsDisease AttributesPathologic Processes

Intervention Hierarchy (Ancestors)

TherapeuticsRehabilitation

Study Officials

  • John F. McLaughlin

    Seattle Children's Hospital

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Purpose
TREATMENT
Sponsor Type
NIH

Study Record Dates

First Submitted

February 24, 2000

First Posted

February 25, 2000

Study Start

October 1, 1991

Last Updated

June 24, 2005

Record last verified: 1997-02